Table 3.
Treatment | Challenge Dose | DPB | % Survival | Risk Ratio | Prob > Chisq | Lower 95% | Upper 95% |
---|---|---|---|---|---|---|---|
RCN-F1 | low | 21 | 0 | 3.69 | 0.08 | 0.85 | 25.26 |
42 | 0 | 4.59 | 0.04 | 1.04 | 31.77 | ||
high | 21 | 0 | 5.00 | 0.03 | 1.12 | 34.67 | |
42 | 0 | 9.70 | 0.00 | 2.16 | 67.82 | ||
RCN-F1 + RCN-V307 | low | 21 | 50 | 1.51 | 0.65 | 0.25 | 11.48 |
42 | 33 | 2.36 | 0.31 | 0.46 | 17.02 | ||
high | 21 | 0 | 8.29 | 0.01 | 1.87 | 57.44 | |
42 | 50 | 1.69 | 0.56 | 0.28 | 12.84 | ||
RCN-F1/V307 | low | 21 | 50 | 1.56 | 0.62 | 0.26 | 11.84 |
42 | 50 | 1.69 | 0.56 | 0.28 | 12.84 | ||
high | 21 | 50 | 1.44 | 0.68 | 0.24 | 10.96 | |
42 | 67 | 1.00 |